Le Lézard
Classified in: Health
Subject: RCL

CORRECTION NOTICE: New Hampshire Laboratory Error Incorrectly Resulted in Recall of l?f Farms "Spice" Packaged Salad Greens: Recall Canceled


CONCORD, N.H., May 11, 2023 /PRNewswire/ -- The New Hampshire Department of Health and Human Services (DHHS) has determined that a laboratory error incorrectly caused last week's recall announcement concerning l?f Farms "Spice" Packaged Salad Greens. The products from l?f Farms are safe and the recall has been canceled.

On May 5, a press release was issued regarding a potential contamination of Escherichia coli O157 bacteria of a specific lot of l?f Farms "Spice" Packaged Salad Greens. Upon being informed, l?f Farms voluntarily initiated a recall of the potentially affected products, prioritizing the health and safety of their customers. Subsequent whole genome sequencing was conducted, which determined that the control sample and the l?f Farms sample were nearly identical, indicating that the initial lab results were inaccurate due to a contamination error within the lab itself.

"I wish to apologize to l?f Farms, their customers and the public for this unfortunate event," said Division of Public Health Services (DPHS) Director Tricia Tilley. "l?f Farms' quick and decisive actions put the health of their customers first. Their products are safe for consumers. We appreciate that l?f Farms has been a willing partner in this process. While this situation is unprecedented, our dedicated staff will embrace all corrective actions to ensure it will not occur again."

Shawn Jasper, State Commissioner of Agriculture, Markets and Food added: "After a two-day inspection of l?f Farms' facility and products, what we discovered was a company that operates at the highest level of food safety and integrity. We are working closely with the FDA and l?f Farms to make this right."

l?f Farms is a subsidiary of BrightFarms, a national leader in the booming indoor farming industry, which is transforming how produce is grown and delivered with its expanding network of high-tech, sustainable hydroponic farms.

"We are relieved to confirm that this was merely a lab mistake, and our product was never at risk. Customer health and safety remain our top priority. I'm immensely proud of our team's swift response and effective collaboration with FDA and state officials," said Steve Platt, CEO of BrightFarms.

With the recall canceled, l?f Farms "Spice" is returning to store shelves in Hannaford and Market Basket in Maine, Massachusetts, New Hampshire, New York, Rhode Island and Vermont. There is no longer any need for consumers who have purchased the l?f Farms "Spice" products to discard them or seek refunds from their place of purchase. Consumers with questions are encouraged to call l?f Farms at 1-866-857-8745 between 8:00am-6:00pm EDT or email [email protected] with the subject line: Recall.

The PHL has not experienced a false positive from routine testing that resulted in a voluntary recall in more than twenty years. DHHS is working closely with the U.S. Food and Drug Administration (FDA) to confirm the source of the contamination and will implement necessary protocol changes to ensure it is not repeated. DHHS has been in communication with l?f Farms, the NH Department of Agriculture, Markets and Food, and the FDA. Based on the results of the investigation of the contaminated sample, the PHL will implement corrective actions to protect consumers, manufacturers and food producers, and the general public.

This is a correction to the press release issued on May 4, 2023 with the headline: "l?f Farms Recalls "Spice" Packaged Salad Greens Because of Possible Health Risk."

SOURCE New Hampshire Department of Health and Human Services


These press releases may also interest you

at 03:20
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

3 jui 2024
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...



News published on and distributed by: